Riluzole and Mirtazapine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Riluzole and Mirtazapine. Common interactions include apathy among females and hospitalisation among males.

The phase IV clinical study analyzes what interactions people who take Riluzole and Mirtazapine have. It is created by eHealthMe based on reports of 7 people who take Riluzole and Mirtazapine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 29, 2022

7 people who take Riluzole and Mirtazapine together, and have interactions are studied.


What is Riluzole?

Riluzole has active ingredients of riluzole. It is often used in amyotrophic lateral sclerosis. eHealthMe is studying from 1,212 Riluzole users for its effectiveness, alternative drugs and more.

What is Mirtazapine?

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 68,173 Mirtazapine users for its effectiveness, alternative drugs and more.

Number of Riluzole and Mirtazapine reports submitted per year:

Riluzole and Mirtazapine drug interactions.

Common Riluzole and Mirtazapine drug interactions by gender *:

female:

  1. Apathy
  2. Disturbance in attention
  3. Personality change

male:

  1. Hospitalisation
  2. Drug ineffective
  3. Hepatitis acute
  4. Hyperglycaemia
  5. Restlessness
  6. Somnolence
  7. Sudden death

Common Riluzole and Mirtazapine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Apathy
  2. Disturbance in attention
  3. Hyperglycaemia
  4. Personality change

60+:

  1. Hospitalisation
  2. Drug ineffective
  3. Hepatitis acute
  4. Restlessness
  5. Somnolence
  6. Sudden death

* Approximation only. Some reports may have incomplete information.

Do you take Riluzole and Mirtazapine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Riluzole and Mirtazapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Riluzole side effects:

Browse all side effects of Riluzole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mirtazapine side effects:

Browse all side effects of Mirtazapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Riluzole interactions:

Browse all interactions between Riluzole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mirtazapine interactions:

Browse all interactions between Mirtazapine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on riluzole and mirtazapine (the active ingredients of Riluzole and Mirtazapine, respectively), and Riluzole and Mirtazapine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Riluzole and Mirtazapine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: